공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 영아연축 치료제 시장

Global Infantile Spasms Therapeutics Market Professional Survey Report 2017

리서치사 QYResearch
발행일 2017년 12월 상품 코드 597663
페이지 정보 영문
가격
US $ 3,500 ₩ 3,984,000 PDF (Single User License)
US $ 7,000 ₩ 7,968,000 PDF (Enterprise Wide License)


세계의 영아연축 치료제 시장 Global Infantile Spasms Therapeutics Market Professional Survey Report 2017
발행일 : 2017년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 영아연축 치료제(Infantile Spasms Therapeutics) 시장에 대해 조사했으며, 시장 및 제품 정의와 개요, 종류·용도·지역/주요 국가별 시장 규모 추정과 예측, 시장에 대한 각종 영향요인, 경쟁 상황과 시장 점유율, 주요 제조업체 개요 등의 정보를 전해드립니다.

제1장 산업 개요

  • 제품 정의와 사양
  • 시장 분석과 예측 : 종류별
    • 제조량과 성장률 비교
    • 시장 점유율
    • 경구약
    • 주사제
  • 시장 분석과 예측 : 용도별
    • 소비량 비교
    • 병원
    • 진료소
  • 시장 분석과 예측 : 지역별
  • 시장 규모 추정

제2장 제조 비용 분석

  • 원재료와 공급업체
  • 제조 비용 구조
  • 제조 공정 분석
  • 산업 체인 구조
  • 기술 진보
  • 정치 경제 환경의 변화

제3장 테크니컬 데이터와 제조 공장

  • 주요 제조업체의 제조능력 등
  • 주요 제조업체의 본사 분포
  • 제품 브랜드
  • M&A, 확장
  • FDA 승인

제4장 전체 시장 분석

  • 전체 시장 분석
  • 제조능력 분석
  • 판매량 분석
  • 공장도가격 분석

제5장 시장 분석 : 지역별

  • 미국
  • 중국
  • 유럽
  • 일본
  • 아시아 기타 지역
  • 기타 지역
    • 시장 개요
    • 지역 공급량, 수출입량, 지역 소비량 추정
    • 가격 분석
    • 시장 점유율 분석

제6장 시장 추정 : 종류별

제7장 시장 추정 : 용도별

제8장 주요 제조업체

  • Mallinckrodt
  • H. Lundbeck
  • Insys Therapeutics
  • Orphelia Pharma
  • Valerion Therapeutics
  • Catalyst Pharmaceuticals
  • Anavex Life Sciences
  • Retrophin
  • GW Pharmaceuticals

제9장 시장 예측

  • 세계 시장 예측
  • 시장 예측 : 지역별
  • 시장 동향 : 제품 종류별
  • 시장 동향 : 용도별

제10장 마케팅 분석

  • 마케팅 경로
  • 시장 포지셔닝
  • 유통 판매업체 리스트

제11장 소비자 분석

제12장 결론

제13장 조사 방법과 데이터 소스

KSM 18.01.09

In the last several years, global market of Infantile Spasms Therapeutics developed steadily, with an average growth rate of 2.9%. In 2016, global revenue of Infantile Spasms Therapeutics is nearly 130 million USD; the actual production is about 6340 units.

This report studies Infantile Spasms Therapeutics in Global market, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering:

  • Mallinckrodt
  • H. Lundbeck
  • Insys Therapeutics
  • Orphelia Pharma
  • Valerion Therapeutics
  • Catalyst Pharmaceuticals
  • Anavex Life Sciences
  • Retrophin
  • GW Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with production, sales, revenue, and market share and growth rate of Infantile Spasms Therapeutics in these regions, from 2012 to 2022 (forecast), like:

  • United States
  • Europe
  • China
  • Japan
  • RoA
  • RoW

Split by Product Type, with production, revenue, price, and market share and growth rate of each type, can be divided into:

  • Oral
  • Injection

Split by application, this report focuses on sales, market share and growth rate of Infantile Spasms Therapeutics in each application, can be divided into:

  • Hospital
  • Clinic
  • Other

Note: RoW: Rest of World, RoA: Rest of Asia.

Table of Contents

1. Industry Overview of Infantile Spasms Therapeutics

  • 1.1. Definition and Specifications of Infantile Spasms Therapeutics
  • 1.2 Infantile Spasms Therapeutics Segment by Types (Product Category)
    • 1.2.1. Global Infantile Spasms Therapeutics Production and Growth Rate (%) Comparison by Types (2012-2022)
    • 1.2.2. Global Infantile Spasms Therapeutics Production Market Share (%) by Types in 2016
    • 1.2.3. Oral
    • 1.2.4. Injection
  • 1.3. Global Infantile Spasms Therapeutics Segment by Applications
    • 1.3.1. Global Infantile Spasms Therapeutics Consumption Comparison by Applications (2012-2022)
    • 1.3.2. Hospital
    • 1.3.3. Clinic
  • 1.4. Global Infantile Spasms Therapeutics Market by Regions
    • 1.4.1. Global Infantile Spasms Therapeutics Market Size and Growth Rate Comparison by Regions (2012-2022)
    • 1.4.2. United States Infantile Spasms Therapeutics Status and Prospect (2012-2017)
    • 1.4.3. China Infantile Spasms Therapeutics Status and Prospect (2012-2017)
    • 1.4.4. Europe Infantile Spasms Therapeutics Status and Prospect (2012-2017)
    • 1.4.5. Japan Infantile Spasms Therapeutics Status and Prospect (2012-2017)
    • 1.4.6. RoA Infantile Spasms Therapeutics Status and Prospect (2012-2017)
    • 1.4.7. RoW Infantile Spasms Therapeutics Status and Prospect (2012-2017)
  • 1.5. Global Infantile Spasms Therapeutics Market Size (2012-2017)
    • 1.5.1. Global Infantile Spasms Therapeutics Sales Revenue Status and Outlook (2012-2017)
    • 1.5.2. Global Infantile Spasms Therapeutics Capacity, Production Status and Outlook (2012-2017)

2. Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics

  • 2.1. Raw Material and Suppliers
  • 2.2. Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics
    • 2.2.1. Raw Materials
    • 2.2.2. Labor Cost Analysis
    • 2.2.3. Other Costs Analysis
  • 2.3. Manufacturing Process Analysis of Infantile Spasms Therapeutics
  • 2.4. Industry Chain Structure of Infantile Spasms Therapeutics
    • 2.4.1 Infantile Spasms Therapeutics R&D Cost Analysis
    • 2.4.2. Clinical Phase Costs
    • 2.4.3. Capitalized Costs
  • 2.5. Technology Progress
  • 2.6. Economic/Political Environmental Change

3. Technical Data and Manufacturing Plants Analysis of Infantile Spasms Therapeutics

  • 3.1. Capacity and Founded Date of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
  • 3.2. Headquarter of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
  • 3.3. Product Brands of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
  • 3.4. Mergers. Acquisitions, Expansion
  • 3.5. FDA Approvals

4. Global Infantile Spasms Therapeutics Overall Market Overview

  • 4.1. 2012-2017 Overall Market Analysis
  • 4.2. Capacity Analysis
    • 4.2.1. 2012-2017 Global Infantile Spasms Therapeutics Capacity and Growth Rate Analysis
    • 4.2.2. 2016 Infantile Spasms Therapeutics Capacity Analysis (Company Segment)
  • 4.3. Sales Analysis
    • 4.3.1. 2012-2017 Global Infantile Spasms Therapeutics Sales and Growth Rate Analysis
    • 4.3.2. 2016 Infantile Spasms Therapeutics Sales Analysis (Company Segment)
  • 4.4. Ex-factory Price Analysis
    • 4.4.1. 2012-2017 Global Infantile Spasms Therapeutics Ex-factory Price
    • 4.4.2. 2016 Infantile Spasms Therapeutics Ex-factory Price Analysis (Company Segment)

5 Infantile Spasms Therapeutics Regional Market Analysis

  • 5.1. United States Infantile Spasms Therapeutics Market Analysis
    • 5.1.1. United States Infantile Spasms Therapeutics Market Overview
    • 5.1.2. United States 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.1.3. United States 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.1.4. United States 2016 Infantile Spasms Therapeutics Market Share Analysis
  • 5.2. China Infantile Spasms Therapeutics Market Analysis
    • 5.2.1. China Infantile Spasms Therapeutics Market Overview
    • 5.2.2. China 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.2.3. China 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.2.4. China 2016 Infantile Spasms Therapeutics Market Share Analysis
  • 5.3. Europe Infantile Spasms Therapeutics Market Analysis
    • 5.3.1. Europe Infantile Spasms Therapeutics Market Overview
    • 5.3.2. Europe 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.3.3. Europe 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.3.4. Europe 2016 Infantile Spasms Therapeutics Market Share Analysis
  • 5.4. Japan Infantile Spasms Therapeutics Market Analysis
    • 5.4.1. Japan Infantile Spasms Therapeutics Market Overview
    • 5.4.2. Japan 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.4.3. Japan 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.4.4. Japan 2016 Infantile Spasms Therapeutics Market Share Analysis
  • 5.5. RoA Infantile Spasms Therapeutics Market Analysis
    • 5.5.1. RoA Infantile Spasms Therapeutics Market Overview
    • 5.5.2. RoA 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.5.3. RoA 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.5.4. RoA 2016 Infantile Spasms Therapeutics Market Share Analysis
  • 5.6. RoW Infantile Spasms Therapeutics Market Analysis
    • 5.6.1. RoW Infantile Spasms Therapeutics Market Overview
    • 5.6.2. RoW 2012-2017 Infantile Spasms Therapeutics Local Supply, Import, Export, Local Consumption Analysis
    • 5.6.3. RoW 2012-2017 Infantile Spasms Therapeutics Sales Price Analysis
    • 5.6.4. RoW 2016 Infantile Spasms Therapeutics Market Share Analysis

6. Global 2012-2017 Infantile Spasms Therapeutics Segment Market Analysis (by Type)

  • 6.1. Global 2012-2017 Infantile Spasms Therapeutics Sales by Type
  • 6.2. Different Types Infantile Spasms Therapeutics Product Interview Price Analysis
  • 6.3. Different Types Infantile Spasms Therapeutics Product Driving Factors Analysis
    • 6.3.1. Oral Growth Rate Analysis
    • 6.3.2. Injection Growth Rate Analysis
  • 6.4. Different Types Infantile Spasms Therapeutics Product Driving Factors Analysis

7. Global 2012-2017 Infantile Spasms Therapeutics Segment Market Analysis (by Application)

  • 7.1. Global 2012-2017 Infantile Spasms Therapeutics Consumption by Application
  • 7.2. Different Application Infantile Spasms Therapeutics Product Interview Price Analysis
  • 7.3. Different Application Infantile Spasms Therapeutics Product Driving Factors Analysis
    • 7.3.1. Hospital Growth Rate Analysis
    • 7.3.2. Clinic Growth Rate Analysis
  • 7.4. Different Application Infantile Spasms Therapeutics Product Driving Factors Analysis

8. Analysis of Infantile Spasms Therapeutics Industry Key Manufacturers

  • 8.1. Mallinckrodt
    • 8.1.1. Company Profile
    • 8.1.2. Product Information
    • 8.1.3. Sales, Price, Cost, Gross, and Revenue
    • 8.1.4. Mallinckrodt 2016 Nitinol-based Medical Device Business Region Distribution Analysis
  • 8.2. H. Lundbeck
    • 8.2.1. Company Profile
    • 8.2.2. Product Information
    • 8.2.3. Sales, Price, Cost, Gross, and Revenue
    • 8.2.4. H. Lundbeck 2016 Nitinol-based Medical Device Business Region Distribution Analysis
  • 8.2. Insys Therapeutics
    • 8.2.1. Company Profile
    • 8.2.2. Product Information
  • 8.4. Orphelia Pharma
    • 8.4.1. Company Profile
    • 8.4.2. Product Information
  • 8.5. Valerion Therapeutics
    • 8.5.1. Company Profile
  • 8.6. Catalyst Pharmaceuticals
    • 8.6.1. Company Profile
    • 8.6.2. Product Information
  • 8.7. Anavex Life Sciences
    • 8.7.1. Company Profile
    • 8.7.2. Product Information
  • 8.8. Retrophin
    • 8.8.1. Company Profile
  • 8.9. GW Pharmaceuticals
    • 8.9.1. Company Profile
    • 8.9.2. Product Information

9. Development Trend of Analysis of Infantile Spasms Therapeutics Market

  • 9.1. Global Infantile Spasms Therapeutics Market Trend Analysis
    • 9.1.1. Global 2017-2022 Infantile Spasms Therapeutics Market Size (Volume and Value) Forecast
    • 9.1.2. Global 2017-2022 Infantile Spasms Therapeutics Ex-factory Price Forecast
  • 9.2 Infantile Spasms Therapeutics Regional Market Trend
    • 9.2.1. United States 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
    • 9.2.2. China 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
    • 9.2.3. Europe 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
    • 9.2.4. Japan 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
    • 9.2.5. RoA 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
    • 9.2.6. RoW 2017-2022 Infantile Spasms Therapeutics Consumption Forecast
  • 9.3 Infantile Spasms Therapeutics Market Trend (Product Type)
  • 9.4 Infantile Spasms Therapeutics Market Trend (Application)

10 Infantile Spasms Therapeutics Marketing Type Analysis

  • 10.1. Marketing Channel
    • 10.1.1. Direct Marketing
    • 10.1.2. Indirect Marketing
    • 10.1.3. Marketing Channel Development Trend
  • 10.2. Market Positioning
    • 10.2.1. Pricing Strategy
    • 10.2.2. Brand Strategy
  • 10.3. Traders or Distributors with Contact Information of Infantile Spasms Therapeutics

11. Consumers Analysis of Infantile Spasms Therapeutics

  • 11.1. Mayo Clinic Analysis
  • 11.2. Boston Children's Hospital Analysis
  • 11.3. Royal Brompton Hospital Analysis
  • 11.4. Johns Hopkins Hospital Analysis
  • 11.5. Ohio State University Wexner Medical Center
  • 11.6. University of Iowa Hospitals and Clinics

12. Conclusion of the Infantile Spasms Therapeutics Market

13. Methodology and Data Source

  • 13.1. Methodology/Research Approach
    • 13.1.1. Research Programs/Design
    • 13.1.2. Market Size Estimation
    • 13.1.3. Market Breakdown and Data Triangulation
  • 13.2. Data Source
    • 13.2.1. Secondary Sources
    • 13.2.2. Primary Sources
  • 13.3. Disclaimer
  • 13.4. Author List

List of Tables and Figures

  • Figure Picture of Infantile Spasms Therapeutics
  • Table Global Infantile Spasms Therapeutics Production (Unit) and Growth Rate (%) Comparison by Types (2012-2022)
  • Figure Global Infantile Spasms Therapeutics Production Market Share (%) by Types in 2016
  • Figure Product Picture of Oral
  • Figure Product Picture of Injection
  • Table Global Infantile Spasms Therapeutics Consumption (Unit) Comparison by Applications (2012-2022)
  • Figure Global Infantile Spasms Therapeutics Consumption Market Share (%) by Applications in 2016
  • Figure Hospitals Examples
  • Figure Clinics Examples
  • Table Global Infantile Spasms Therapeutics Sales (Unit) Comparison by Regions (2012-2022)
  • Figure United States Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
  • Figure China Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
  • Figure Europe Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
  • Figure Japan Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2022)
  • Figure RoA Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
  • Figure RoW Infantile Spasms Therapeutics Sales Revenue (M USD) and Growth Rate (2012-2017)
  • Figure Global Infantile Spasms Therapeutics Sales Revenue (M USD) Status and Outlook (2012-2017)
  • Figure Global Infantile Spasms Therapeutics Capacity (Unit) Status and Outlook (2012-2017)
  • Figure Global Infantile Spasms Therapeutics Production (Unit) Status and Outlook (2012-2017)
  • Table Infantile Spasms Therapeutics Raw Material and Suppliers
  • Table Raw Material Suppliers Analysis and Contact Information
  • Figure Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics in 2016
  • Figure USA Labor Cost Analysis 2012-2016
  • Figure Cost of Employing a Factory Worker
  • Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs 2013-2016
  • Table Average Price of Electricity to Ultimate Customers 2007-2016
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Manufacturing Process Analysis of Infantile Spasms Therapeutics
  • Figure Typical Phases from Research to the Market for a Drug Candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Figure Global GDP Map 2016
  • Figure EU GDP Change 2006-2016
  • Figure Germany CPI Change 2016-2017
  • Figure UK CPI Change 2007-2016
  • Figure Japan GDP Change 2014-2017
  • Figure Japan CPI Change in 2016
  • Figure China GDP Change 2014-2017
  • Figure China CPI Change 2016-2017
  • Figure US GDP Change 2013-2016
  • Figure US CPI Change 2016-2017
  • Table Capacity (Unit) and Founded Date of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
  • Table Headquarter of Global Infantile Spasms Therapeutics Major Manufacturers in 2016
  • Table Manufacturers Infantile Spasms Therapeutics Product Brands
  • Table Mergers & Acquisitions, Expansion
  • Table H.P. Acthar Gel FDA Approvals Introduction
  • Table Sabril (vigabatrin) FDA Approvals Introduction
  • Table Global Capacity (Unit), Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Sales Revenue (M USD) and Gross Margin of Infantile Spasms Therapeutics 2012-2017
  • Figure Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) and Growth Rate
  • Figure Global 2012-2017 Infantile Spasms Therapeutics Revenue Market Size (M USD) and Growth Rate
  • Figure 2012-2017 Global Infantile Spasms Therapeutics Capacity and Growth Rate
  • Table 2016 Global Infantile Spasms Therapeutics Capacity (Unit) List (Company Segment)
  • Figure 2012-2017 Global Infantile Spasms Therapeutics Sales (Unit) and Growth Rate
  • Table 2016 Global Infantile Spasms Therapeutics Sales (Unit) List (Company Segment)
  • Figure 2012-2017 Global Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit)
  • Table 2016 Global Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit) List (Company Segment)
  • Table United States Supply, Consumption Overview (Unit)
  • Table United States Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure United States 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Figure United States 2016 Infantile Spasms Therapeutics Sales Market Share
  • Table China Supply, Consumption Overview (Unit)
  • Table China Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure China 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Table China 2016 Infantile Spasms Therapeutics Sales (Unit)
  • Table Europe Supply, Consumption Overview (Unit)
  • Table Europe Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure Europe 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Figure Europe 2016 Infantile Spasms Therapeutics Sales Market Share
  • Table Japan Supply, Consumption Overview (Unit)
  • Table Japan Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure Japan 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Table Japan 2016 Infantile Spasms Therapeutics Sales (Unit)
  • Table RoA Supply, Consumption Overview (Unit)
  • Table RoA Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure RoA 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Table RoA 2016 Infantile Spasms Therapeutics Sales (Unit)
  • Table RoW Supply, Consumption Overview (Unit)
  • Table RoW Supply, Import, Export and Consumption of Infantile Spasms Therapeutics 2012-2017 (Unit)
  • Figure RoW 2012-2017 Infantile Spasms Therapeutics Sales Price (K USD/Unit)
  • Table RoW 2016 Infantile Spasms Therapeutics Sales (Unit)
  • Table Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) by Type
  • Table Different Types Infantile Spasms Therapeutics Product Interview Price
  • Figure Oral Growth Rate Analysis
  • Figure Injection Growth Rate Analysis
  • Table Global 2012-2017 Infantile Spasms Therapeutics Sales (Unit) by Application
  • Table Different Application Infantile Spasms Therapeutics Product Interview Price
  • Figure Hospital Growth Rate Analysis
  • Figure Clinic Growth Rate Analysis
  • Figure Global New Born
  • Table Mallinckrodt Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of Mallinckrodt
  • Table Infantile Spasms Therapeutics Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Gross (K USD/Unit), Revenue (M USD) and Gross Margin of Mallinckrodt 2016-2017
  • Figure 2016 Mallinckrodt Nitinol-based Medical Device Business Region Distribution
  • Table H. Lundbeck Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of H. Lundbeck
  • Table Infantile Spasms Therapeutics Sales (Unit), Price (K USD/Unit), Cost (K USD/Unit), Gross (K USD/Unit), Revenue (M USD) and Gross Margin of H. Lundbeck 2016-2017
  • Figure 2016 H. Lundbeck Nitinol-based Medical Device Business Region Distribution
  • Table Insys Therapeutics Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of Insys Therapeutics
  • Table Orphelia Pharma Company Profile
  • Table Valerion Therapeutics Company Profile
  • Table Catalyst Pharmaceuticals Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of Catalyst Pharmaceuticals
  • Table Anavex Life Sciences Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of Anavex Life Sciences
  • Table Retrophin Company Profile
  • Table GW Pharmaceuticals Company Profile
  • Figure Infantile Spasms Therapeutics Product Introduction of GW Pharmaceuticals
  • Figure Global 2017-2022 Infantile Spasms Therapeutics Sales (Unit) and Growth Rate Forecast
  • Figure Global 2017-2022 Infantile Spasms Therapeutics Market Size (M USD) and Growth Rate Forecast
  • Figure Global 2017-2022 Infantile Spasms Therapeutics Ex-factory Price (K USD/Unit) Forecast
  • Figure United States 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Figure China 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Figure Europe 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Figure Japan 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Figure RoA 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Figure RoW 2017-2022 Infantile Spasms Therapeutics Consumption Volume and Growth Rate Forecast
  • Table Global Sales Volume (Unit) of Infantile Spasms Therapeutics by Type 2017-2022
  • Table Global Sales Volume Market Share of Infantile Spasms Therapeutics by Type 2017-2022
  • Table Global Consumption Volume (Unit) of Infantile Spasms Therapeutics by Application 2017-2022
  • Table Global Consumption Volume Market Share of Infantile Spasms Therapeutics by Application 2017-2022
  • Figure Market Channel of Infantile Spasms Therapeutics
  • Table Traders or Distributors with Contact Information of Infantile Spasms Therapeutics
  • Table Mayo Clinic Information List
  • Table Boston Children's Hospital Information List
  • Table Royal Brompton Hospital Information List
  • Table Johns Hopkins Hospital Information List
  • Table Ohio State University Wexner Medical Center Information List
  • Table University of Iowa Hospitals and ClinicsInformation List
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top
전화 문의
F A Q